ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

D. J. Stone, C. Molony, C. Suver, E. E. Schadt, W. Z. Potter

Research output: Contribution to journal › Short survey › peer-review

16 Scopus citations

Access to Document

@article{4d7d2521e7a74420abde109b6087e9cd,

title = "ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease",

author = "Stone, {D. J.} and C. Molony and C. Suver and Schadt, {E. E.} and Potter, {W. Z.}",

year = "2010",

month = jun,

doi = "10.1038/tpj.2009.58",

language = "English",

volume = "10",

pages = "161--164",

journal = "Pharmacogenomics Journal",

issn = "1470-269X",

publisher = "Springer Nature",

number = "3",

}

TY - JOUR

T1 - ApoE genotyping as a progression-rate biomarker in phase II disease-modification trials for Alzheimer's disease

AU - Stone, D. J.

AU - Molony, C.

AU - Suver, C.

AU - Schadt, E. E.

AU - Potter, W. Z.

PY - 2010/6

Y1 - 2010/6

UR - http://www.scopus.com/inward/record.url?scp=77952886323&partnerID=8YFLogxK

U2 - 10.1038/tpj.2009.58

DO - 10.1038/tpj.2009.58

M3 - Short survey

C2 - 19997085

AN - SCOPUS:77952886323

SN - 1470-269X

VL - 10

SP - 161

EP - 164

JO - Pharmacogenomics Journal

JF - Pharmacogenomics Journal

IS - 3

ER -